000 01554 a2200481 4500
005 20250516203955.0
264 0 _c20141007
008 201410s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2014.116
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchneider, V
245 0 0 _aLeukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy.
_h[electronic resource]
260 _bLeukemia
_cAug 2014
300 _a1759-62 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aADP-ribosyl Cyclase 1
_xanalysis
650 0 4 _aAntigens, CD
_xanalysis
650 0 4 _aAntigens, CD34
_xanalysis
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aInterleukin-12
_xphysiology
650 0 4 _aLeukemia, Myeloid, Acute
_xgenetics
650 0 4 _aMutation
650 0 4 _aNeoplastic Stem Cells
_xmetabolism
650 0 4 _aNuclear Proteins
_xgenetics
650 0 4 _aNucleophosmin
650 0 4 _aReceptors, Interleukin-12
_xgenetics
700 1 _aZhang, L
700 1 _aBullinger, L
700 1 _aRojewski, M
700 1 _aHofmann, S
700 1 _aWiesneth, M
700 1 _aSchrezenmeier, H
700 1 _aGötz, M
700 1 _aBotzenhardt, U
700 1 _aBarth, T F E
700 1 _aDöhner, K
700 1 _aDöhner, H
700 1 _aGreiner, J
773 0 _tLeukemia
_gvol. 28
_gno. 8
_gp. 1759-62
856 4 0 _uhttps://doi.org/10.1038/leu.2014.116
_zAvailable from publisher's website
999 _c23682667
_d23682667